Efficacy of treatments for patients with obsessive-compulsive disorder: a systematic review

Journal of the American Academy of Nurse Practitioners
Yun-Jung Choi


This systematic review examines the efficacy of pharmacological therapy for obsessive-compulsive disorder (OCD), addressing two major issues: which treatment is most effective in treating the patient's symptoms and which is beneficial for maintaining remission. Seven databases were used to acquire articles. The key words used to search for the relative topics published from 1996 to 2007 were "obsessive-compulsive disorder" and "Yale-Brown obsession-compulsion scale." Based on the inclusion and exclusion criteria, 25 studies were selected from 57 potentially relevant studies. The effects of treatment with clomipramine and selective serotonin reuptake inhibitors (SSRIs: fluvoxamine, sertraline, fluoxetine, citalopram, and escitalopram) proved to be similar, except for the lower adherence rate in case of clomipramine because of its side effects. An adequate drug trial involves administering an effective daily dose for a minimum of 8 weeks. An augmentation strategy proven effective for individuals refractory to monotherapy with SSRI treatment alone is the use of atypical antipsychotics (risperidone, olanzapine, and quetiapine). Administration of fluvoxamine or sertraline to patients for an adequate duration is recommended as the fi...Continue Reading


Apr 1, 1996·Journal of Clinical Psychopharmacology·L M KoranM A Jenike
Feb 1, 1996·Controlled Clinical Trials·A R JadadH J McQuay
May 1, 1996·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·J J López-IborJ C Gómez-Pérez
Nov 11, 1998·Depression and Anxiety·C Cartwright, E Hollander
Dec 8, 1998·JAMA : the Journal of the American Medical Association·J S MarchH Steiner
Jan 5, 2002·The American Journal of Psychiatry·Lorrin M KoranDelbert Robinson
Mar 23, 2002·Journal of Clinical Psychopharmacology·Richard BergeronVratislav Hadrava
Nov 26, 2002·Journal of the American Academy of Child and Adolescent Psychiatry·Michael R LiebowitzH Blair Simpson
Jun 6, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Giuseppina D'AmicoEdoardo Spina
Aug 19, 2003·Human Psychopharmacology·Ozmen MetinAylin Ertekin Yazici
Nov 3, 2004·Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists·Barbara A CrockettJonathan R T Davidson
Dec 2, 2004·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Stefano ErzegovesiLaura Bellodi
Feb 11, 2005·Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists·Per Hove Thomsen
May 3, 2005·The American Journal of Psychiatry·Rocco CrinoGavin Andrews
Jun 4, 2005·International Clinical Psychopharmacology·Naomi A FinebergTim Gale
Jun 29, 2005·Journal of Psychopharmacology·Donatella MarazzitiLiliana Dell'Osso
Jan 24, 2007·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Naomi A FinebergDan J Stein
Feb 13, 2007·International Clinical Psychopharmacology·Femke de GeusHerman G M Westenberg
Aug 11, 2007·Progress in Neuro-psychopharmacology & Biological Psychiatry·Leonardo F Fontenelle, Gregor Hasler
Jan 1, 1997·European Psychiatry : the Journal of the Association of European Psychiatrists·J BisserbeUNKNOWN Franco-Belgian OCD Study Group

❮ Previous
Next ❯


Nov 16, 2012·Clinical Neuropharmacology·Giovanni CamardeseLuigi Janiri
Feb 14, 2015·Human Psychopharmacology·Daniele SerataAntonio Del Casale
Jan 26, 2018·The Cochrane Database of Systematic Reviews·Paul R L MatthewsMichael Pearce
May 8, 2013·Clinical Chemistry and Laboratory Medicine : CCLM·Giuseppe LippiMassimo Franchini
Jan 1, 2013·Trends in psychiatry and psychotherapy·Adelar Pedro FranzYgor Arzeno Ferrão

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.